GlassScriptPhysician profile
Matthew Beidleman
NPI 1548799885
$11,381.60
in general payments reported to CMS, 2019-2025
9 companies · $350 in 2025
The $350 reported for 2025 was more than what 78% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10K · 2021: $544 · 2022: $12.29 · 2023: $98.93 · 2024: $343 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,125.00 | 2020-2021 | |
| Bioventus LLC | $433.75 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $267.60 | 2021 | |
| Zimmer Biomet Holdings, INC. | $200.76 | 2020-2024 | Gel-One Cross-Linked Hyaluronate |
| Djo, LLC | $165.25 | 2023-2024 | Chattanooga, Procare, Aircast |
| Prime Surgical, LLC | $79.58 | 2025 | |
| Depuy Synthes Sales INC. | $48.08 | 2021-2024 | Monovisc, Orthovisc |
| Horizon Therapeutics Plc | $40.82 | 2023 | Krystexxa |
| Orthofix Medical, INC. | $20.76 | 2024 | Cervical-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Beidleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.